Emil F Veltre, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1591 Gulf Blvd Apt 203s, Clearwater Beach, FL 33767 Phone: 727-667-5592 |
Dr. Monika Girgis Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 660 S Gulfview Blvd, Clearwater Beach, FL 33767 Phone: 727-443-2393 |
Dr. Roxanne A Rohn, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Cvs Pharmacy, 467 Mandalay Avenue, Clearwater Beach, FL 33767 Phone: 727-447-6429 Fax: 727-441-1619 |
Sarah P Sofianos Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 660 S Gulfview Blvd, Clearwater Beach, FL 33767 Phone: 727-443-2393 |
Dr. Ramona Fatima Santos, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 31 Island Way, Apt 604, Clearwater Beach, FL 33767 Phone: 407-721-8599 |
News Archive
A gene crucial for embryonic development can quickly become a potent cancer promoter in adult mice after a genetic misalignment, according to researchers from Fox Chase Cancer Center, causing white blood cells to become cancerous spontaneously.
Adding an immune checkpoint inhibitor to the standard chemotherapy regimen for patients with early-stage breast cancer places no greater burden on patients' ability to perform day-to-day activities than chemotherapy alone, new research by Dana-Farber/Brigham and Women's Cancer Center investigators shows.
R. Scott Hitt - a former HIV/AIDS physician and former chair of the Presidential Advisory Council on HIV/AIDS during the Clinton administration - died Thursday of colon cancer at his home in West Hollywood, Calif., according to Hitt's friend and West Hollywood Mayor John Duran, the AP/San Francisco Chronicle reports.
It's a fact: each and every January senior living communities see an increase in inquiries from concerned family members looking for help and answers as to how to best care for an aging loved one that needs assistance
Seattle Genetics, Inc. today announced that interim results from an investigator-sponsored phase II clinical trial of ADCETRIS (brentuximab vedotin) in patients with relapsed cutaneous T-cell lymphoma (CTCL) were presented at the Society for Investigative Dermatology annual meeting being held May 9-12, 2012 in Raleigh, NC.
› Verified 8 days ago